A new class of free radical scavengers reducing adriamycin mitochondrial toxicity
- 1 December 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (24) , 4617-4622
- https://doi.org/10.1016/0006-2952(88)90329-2
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Doxorubicin-induced congestive heart failure in adultsCancer, 1985
- Cardiotoxicity of antitumor agentsProgress in Cardiovascular Diseases, 1984
- Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environmentBiochemical and Biophysical Research Communications, 1982
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Evidence of a complex between adriamycin derivatives and cardiolipin: Possible role in cardiotoxicityBiochemical Pharmacology, 1980
- Evidence of a specific complex between adriamycin and negatively-charged phospholipidsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1980
- Effect of doxorubicin and rubidazone on respiratory function and Ca2+ transport in rat heart mitochondriaToxicology Letters, 1979
- Adriamycin: Energy metabolism and mitochondrial oxidations in the heart of treated rabbitsBiochemical Pharmacology, 1976
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- Effects of seven anthracyclin antibiotics on electrocardiogram and mitochondrial function of rat heartsInflammation Research, 1975